An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway-Reference-Cited by-同舟云学术

An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

Published:2011-09-15 Issue:5 Volume:1 Page:442-456
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Guo Deliang,Reinitz Felicia,Youssef Mary,Hong Cynthia,Nathanson David,Akhavan David,Kuga Daisuke,Amzajerdi Ali Nael,Soto Horacio,Zhu Shaojun,Babic Ivan,Tanaka Kazuhiro,Dang Julie,Iwanami Akio,Gini Beatrice,DeJesus Jason,Lisiero Dominique D.,Huang Tiffany T.,Prins Robert M.,Wen Patrick Y.,Robins H. Ian,Prados Michael D.,DeAngelis Lisa M.,Mellinghoff Ingo K.,Mehta Minesh P.,James C. David,Chakravarti Arnab,Cloughesy Timothy F.,Tontonoz Peter,Mischel Paul S.

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 351 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted therapeutical role of low‐density lipoprotein receptor family in high‐grade glioma;Molecular Oncology;2024-09-14

2. Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers;Journal of Experimental & Clinical Cancer Research;2024-09-06

3. Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma;Cell Reports Medicine;2024-09

4. Tumor Metabolism: A New Field for the Treatment of Glioma;Bioconjugate Chemistry;2024-07-16

5. Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma;Cells;2024-07-06